Equity Details
Price & Market Data
Price: $5.28
Daily Change: -$0.22 / 4.17%
Daily Range: $5.08 - $5.43
Market Cap: $44,434,972
Daily Volume: 60,136
Performance Metrics
1 Week: -7.53%
1 Month: -2.82%
3 Months: 7.05%
6 Months: -58.07%
1 Year: -58.90%
YTD: -41.69%
About Atossa Therapeutics, Inc. (ATOS)
Get the latest market data on Atossa Therapeutics, Inc. (ATOS). Price: 5.28, daily change: -$0.22 / 4.17%. Market cap: 44,434,972. Comprehensive performance from 3-month to 1-year.
Company Details
Employees: 14
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.